Mathematical analysis identifies the optimal treatment strategy for epidermal growth factor receptor-mutated non-small cell lung cancer

INTRODUCTION: In Asians, more than half of non-small cell lung cancers (NSCLC) are induced by epidermal growth factor receptor (EGFR) mutations. Although patients carrying EGFR driver mutations display a good initial response to EGFR-Tyrosine Kinase Inhibitors (EGFR-TKIs), additional mutations provo...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Qian, Kobayashi, Susumu S., Haeno, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10568620/
https://www.ncbi.nlm.nih.gov/pubmed/37841421
http://dx.doi.org/10.3389/fonc.2023.1137966

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10568620/
https://www.ncbi.nlm.nih.gov/pubmed/37841421
http://dx.doi.org/10.3389/fonc.2023.1137966

Ejemplares similares